Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class

  1. Porta-Etessam, J.
  2. González-García, N.
  3. Guerrero, Á.L.
  4. García-Azorín, D.
Zeitschrift:
Neurologia

ISSN: 1578-1968,  0213-4853

Datum der Publikation: 2021

Ausgabe: 36

Nummer: 8

Seiten: 638-640

Art: Brief

DOI: 10.1016/J.NRL.2020.10.009 GOOGLE SCHOLAR lock_openOpen Access editor